Références bibliographiques

Bilan d'extension et prise en charge

Stahl M, Kataja VV, Oliveira J; ESMO Guidelines Task Force.
ESMO Minimal Clinical Recommendations for diagnosis, treatment and follow-up of esophageal cancer.
Ann Oncol 2005;16 Suppl 1:i26-7.

Lightdale CJ, Kulkarni KG.
Role of endoscopic ultrasonography in the staging and follow-up of esophageal cancer.
J Clin Oncol 2005;23:4483-9.

van Westreenen HL, Westerterp M, Bossuyt PM, Pruim J, Sloof GW, van Lanschot JJ, et al.
Systematic review of the staging performance of 18F-fluorodeoxyglucose positron emission tomography in esophageal cancer.
J Clin Oncol 2004 ;22:3805-12.

Place de la chirurgie

Hofstetter W, Swisher SG, Correa AM, Hess K, Putnam JB, Ajani JA et al. Treatment outcomes of resected esophageal cancer.
Ann Surg 2002;236:376-84

Akiyama H, Tsurumaru M, Udagawa H, Kajiyama Y. Radical lymph node dissection for cancer of the thoracic esophagus.
Ann Surg 1994 ;220 :364-72

Hulscher JB, van Sandick JW, de Boer AG, Wijnhoven BP, Tijssen JG, Fockens P et al. Extended transthoracic resection compared with limited transhiatal resection for adenocarcinoma of the esophagus.
N Engl J Med 2002;347:1662-9

Place de la chimiothérapie préopératoire

Medical Research Council Oesophageal Cancer Working Group. Surgical resection with or without preoperative chemotherapy in oesophageal cancer : a randomised controlled trial.
Lancet 2002 ;359:1727-33

V. Boige, J. Pignon, B. Saint-Aubert, P. Lasser, T. Conroy, O. Bouché, et al.
Final results of a randomized trial comparing preoperative 5-fluorouracil (F)/cisplatin (P) to surgery alone in adenocarcinoma of stomach and lower esophagus (ASLE): FNLCC ACCORD07-FFCD 9703 trial.
J Clin Oncol, 2007 ; 25, 18S (Suppl. Part I): résumé 4510

P. G. Thirion, S. Michiels, A. Le Maître, J. Tierney, on behalf of the MetaAnalysis of
Chemotherapy in Esophagus Cancer Collaborative Group.
Individual patient data-based meta-analysis assessing pre-operative chemotherapy in resectable oesophageal carcinoma.
J Clin Oncol, 2007 ; 25, 18S (Suppl. Part I): résumé 4512

Place de la chimioradiothérapie préopératoire

Urschel JD, Vasan H. A meta-analysis of randomized controlled trials that compared neoadjuvant chemoradiation and surgery to surgery alone for resectable esophageal cancer.
Am J Surg 2003;185:538-43

Place et modalités de la chimioradiothérapie

Minsky BD, Pajak TF, Ginsberg RJ, Pisansky TM, Martenson J, Komaki R, et al.
INT 0123 (Radiation Therapy Oncology Group 94-05) phase III trial of combined-modality therapy for esophageal cancer: high-dose versus standard-dose radiation therapy.
J Clin Oncol 2002;20:1167-74.

Smith TJ, Ryan LM, Douglass HO, Haller DG, Dayal Y, Kirkwood J et al. Combined chemoradiotherapy vs. radiotherapy alone for early stage squamous cell carcinoma of the esophagus: a study of the Eastern Cooperative Oncology Group.
Int J Radiat Oncol Biol Phys 1998;42:269-76

Wong RK, Malthaner RA, Zuraw L, Rumble RB
Combined modality radiotherapy and chemotherapy in nonsurgical management of localized carcinoma of the esophagus: a practice guideline.
Int J Radiat Oncol Biol Phys 2003;55:930-42.

Thomas CR, Berkey BA, Minsky BD, Gaspar LE, Herskovic A, Rich TA, et al.
Recursive partitioning analysis of pretreatment variables of 416 patients with locoregional esophageal cancer treated with definitive concomitant chemoradiotherapy on Intergroup and Radiation Therapy Oncology Group trials.
Int J Radiat Oncol Biol Phys 2004;58:1405-10.

Place de la chirurgie après chimioradiothérapie

Stahl M, Stuschke M, Lehmann N, Meyer HJ, Walz MK, Seeber S, et al.
Chemoradiation with and without surgery in patients with locally advanced squamous cell carcinoma of the esophagus.
J Clin Oncol. 2005 ;23:2310-7.

L. Bedenne, P. Michel, O. Bouché, C. Milan, C. Mariette, T. Conroy, et al.
Chemoradiation Followed By Surgery Compared With Chemoradiation Alone In Squamous Cancer of the Esophagus : FFCD 9102.
J Clin Oncol 2007;25:1160-8

Télécharger le fichier des références bibliographiques (version pdf)